2 ML sodium hyaluronate 8.4 MG/ML Prefilled Syringe

RxNorm concept 1804513, clinical drug (scd). Prescribable name: sodium hyaluronate 16.8 MG in 2 ML Prefilled Syringe.

RxCUI: 1804513
Term type: Clinical drug (SCD)
Status: Active

Request

curl https://api.healthcare.dev/v1/drugs/rxnorm/1804513 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Concept

Ingredients and related concepts

Ingredients

hyaluronate 62372

Other names

sodium hyaluronate 16.8 MG per 2 ML Prefilled Syringe

Related concepts

sodium hyaluronate 8.4 MG/ML (SCDC, consists of)
Prefilled Syringe (DF, has dose form)
2 ML sodium hyaluronate 8.4 MG/ML Prefilled Syringe [Gel-Syn] (SBD, has tradename)

Linked data

NDCs

RxNorm links no NDCs to this concept.

Use it

Look up 1804513 from code or an agent

curl

curl https://api.healthcare.dev/v1/drugs/rxnorm/1804513 \
  -H "Authorization: Bearer $HDEV_API_KEY"

MCP prompt

Using the healthcare.dev MCP server, look up RxNorm concept 1804513. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.

Get a free key RxNorm docs Connect the MCP server

Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.